RAPT THERAPEUTICS INC. - COMMON STOCK

RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results

10 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Participate in the 11th Annual SVB Leerink Healthcare Conference

09 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 يناير 2022 08:00:08 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports Third Quarter 2021 Financial Results

10 نوفمبر 2021 16:05:02 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Appoints Industry Veteran Lori Lyons-Williams to its Board of Directors

09 نوفمبر 2021 16:01:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Participate in Upcoming Investor Conferences

08 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Upcoming Oral Presentation of RPT193 Phase 1b Data at the 4th Inflammatory Skin Disease Summit

18 أكتوبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1b Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress

30 سبتمبر 2021 09:15:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the 2021 Cantor Virtual Healthcare Conference

20 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present RPT193 Phase 1b Data at 30th European Academy of Dermatology and Venereology Congress

20 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at Upcoming Investor Conferences

03 سبتمبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports Second Quarter 2021 Financial Results

11 أغسطس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

18 يونيو 2021 12:24:30 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

15 يونيو 2021 23:07:25 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

14 يونيو 2021 16:01:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis

14 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

13 يونيو 2021 16:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference

20 مايو 2021 16:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports First Quarter 2021 Financial Results

11 مايو 2021 08:00:02 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis

22 مارس 2021 08:00:01 بحسب Nasdaq GlobeNewswire